Curcumin inhibits MCF‑7 cells by modulating the NF‑κB signaling pathway

  • Authors:
    • Jun‑Li Liu
    • Yan‑Yan Pan
    • Ou Chen
    • Yun Luan
    • Xia Xue
    • Jing‑Jie Zhao
    • Ling Liu
    • Hong‑Ying Jia
  • View Affiliations

  • Published online on: August 31, 2017     https://doi.org/10.3892/ol.2017.6860
  • Pages: 5581-5584
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The present study investigated the inhibitory effect of curcumin on human breast cancer MCF‑7 cells and investigated the potential underlying molecular mechanisms. MCF‑7 cells were cultured with curcumin at different concentrations and time points. The effects of curcumin treatment on breast cancer cell proliferation were studied using a MTT assay. Reverse transcription‑quantitative polymerase chain reaction and western blot analysis were used to assess the mRNA and protein expression levels of B‑cell lymphoma 2 (Bcl‑2) and Bcl‑2‑associated X (Bax), nuclear factor‑κ‑light‑chain‑enhancer of activated B cells (NF‑κB) and inhibitor of NF‑κB‑α (IκBα). The proliferation of MCF‑7 cells in the group treated with curcumin was markedly decreased compared with the control, with the greatest inhibitory effect at a concentration of 20 µM. The expression of Bax mRNA was increased and Bcl‑2 mRNA expression was decreased compared with the control. Additionally, protein expression of NF‑κB and IκB was increased. The data indicate that curcumin is able to inhibit breast cancer cell proliferation, possibly by regulating the NF‑κB signaling pathway.

References

1 

Pu Z, Yuan X, Zhang X, Chen Q and Xie H: Meta-analysis on the association between CYP2D6*10 gene polymorphism and disease free survival of breast cancer patients receiving tamoxifen treatment in Asia. Bangladesh J Pharmacol. 9:652–662. 2014. View Article : Google Scholar

2 

Li Z and Kang Y: Emerging therapeutic targets in metastatic progression: A focus on breast cancer. Pharmacol Ther. 161:79–96. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Chung SS and Vadgama JV: Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. Anticancer Res. 35:39–46. 2015.PubMed/NCBI

4 

Ramachandran C and You W: Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat. 54:269–278. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Li YB, Gao JL, Zhong ZF, Hoi PM, Lee SM and Wang YT: Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacol Rep. 65:700–709. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Ramachandran C, Rodriguez S, Ramachandran R, Nair Raveendran PK, Fonseca H, Khatib Z, Escalon E and Melnick SJ: Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 25:3293–3302. 2005.PubMed/NCBI

7 

Basnet P and Skalko-Basnet N: Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 16:4567–4598. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Chen Y, Shu W, Chen W, Wu Q, Liu H and Cui G: Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol. 101:427–433. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Goel A, Kunnumakkara AB and Aggarwal BB: Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol. 75:787–809. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Wang Y, Yu J, Cui R, Lin J and Ding X: Curcumin in treating breast cancer: A review. J Lab Autom. 21:723–731. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Hatcher H, Planalp R, Cho J, Torti FM and Torti SV: Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci. 65:1631–1652. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, et al: Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res. 13:3423–3430. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Rengarajan T, Nandakumar N, Rajendran P, Haribabu L, Nishigaki I and Balasubramanian MP: D-pinitol promotes apoptosis in MCF-7 cells via induction of p53 and Bax and inhibition of Bcl-2 and NF-κB. Asian Pac J Cancer Prev. 15:1757–1762. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Kim KC, Baek SH and Lee C: Curcumin-induced downregulation of Axl receptor tyrosine kinase inhibits cell proliferation and circumvents chemoresistance in non-small lung cancer cells. Int J Oncol. 47:2296–2303. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Zhou X, Su J, Feng S, Wang L, Yin X, Yan J and Wang Z: Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells. Oncotarget. 7:79076–79088. 2016.PubMed/NCBI

18 

Sha J, Li J, Wang W, Pan L, Cheng J, Li L, Zhao H and Lin W: Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling. Biomed Pharmacother. 84:177–184. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Iqbal B, Ghildiyal A, Sahabjada, Singh S, Arshad M, Mahdi AA and Tiwari S: Antiproliferative and apoptotic effect of curcumin and TRAIL (TNF Related Apoptosis inducing Ligand) in chronic myeloid leukaemic cells. J Clin Diagn Res. 10:XC01–XC05. 2016.PubMed/NCBI

20 

Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY and Orlowski RZ: Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 62:3868–3875. 2002.PubMed/NCBI

21 

Tor YS, Yazan LS, Foo JB, Armania N, Cheah YK, Abdullah R, Imam MU, Ismail N and Ismail M: Induction of apoptosis through oxidative stress-related pathways in MCF-7, human breast cancer cells, by ethyl acetate extract of Dillenia suffruticosa. BMC Complement Altern Med. 14:552014. View Article : Google Scholar : PubMed/NCBI

22 

Oida K, Matsuda A, Jung K, Xia Y, Jang H, Amagai Y, Ahn G, Nishikawa S, Ishizaka S, Jensen-Jarolim E, et al: Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells. Sci Rep. 4:40572014. View Article : Google Scholar : PubMed/NCBI

23 

Colomer C, Marruecos L, Vert A, Bigas A and Espinosa L: NF-κB members left home: NF-κB-independent roles in cancer. biomedicines. 5:pii: E26. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Ghosh S, May MJ and Kopp EB: NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

November 2017
Volume 14 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, J., Pan, Y., Chen, O., Luan, Y., Xue, X., Zhao, J. ... Jia, H. (2017). Curcumin inhibits MCF‑7 cells by modulating the NF‑κB signaling pathway. Oncology Letters, 14, 5581-5584. https://doi.org/10.3892/ol.2017.6860
MLA
Liu, J., Pan, Y., Chen, O., Luan, Y., Xue, X., Zhao, J., Liu, L., Jia, H."Curcumin inhibits MCF‑7 cells by modulating the NF‑κB signaling pathway". Oncology Letters 14.5 (2017): 5581-5584.
Chicago
Liu, J., Pan, Y., Chen, O., Luan, Y., Xue, X., Zhao, J., Liu, L., Jia, H."Curcumin inhibits MCF‑7 cells by modulating the NF‑κB signaling pathway". Oncology Letters 14, no. 5 (2017): 5581-5584. https://doi.org/10.3892/ol.2017.6860